Research Applications of Extended-Release Metformin
Metformin LONG Ozon is an extended-release formulation of metformin hydrochloride, a biguanide compound extensively studied for its cellular metabolic effects. This sustained-release preparation enables researchers to investigate prolonged metformin exposure in laboratory models, offering advantages for studies requiring consistent compound levels over extended periods. Research teams at Stroid UK Shop utilise this formulation to examine metformin’s complex mechanisms of action in cellular energy metabolism studies.
Metabolic Research Mechanisms
In laboratory settings, researchers investigate metformin’s primary mechanism through AMP-activated protein kinase (AMPK) pathway activation. Studies examine how this compound modulates hepatic glucose production, enhances insulin sensitivity pathways, and affects mitochondrial respiratory chain complex I function. The extended-release formulation allows research protocols to maintain steady compound exposure, facilitating investigation of time-dependent metabolic responses. Scientists studying metabolic modulators often compare metformin’s effects alongside other research compounds to understand cellular energy regulation mechanisms. Research applications extend to examining metformin’s effects on cellular autophagy, mTOR signalling pathways, and mitochondrial biogenesis in various cell culture models.
Laboratory Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Metformin Hydrochloride |
| Formulation Type | Extended-Release Tablet |
| Molecular Formula | C₄H₁₁N₅·HCl |
| Molecular Weight | 165.63 g/mol |
| CAS Number | 1115-70-4 |
| Storage Requirements | Room temperature, dry environment |
| Research Classification | Metabolic modulator |
Researchers investigating cellular metabolism often examine metformin in conjunction with selective androgen receptor modulators to understand compound interactions in energy pathway regulation. Advanced studies may incorporate peptide research compounds to examine synergistic effects on metabolic signalling cascades.
Research Compliance Statement
This metformin extended-release formulation is supplied exclusively for in-vitro laboratory research applications. The compound is not approved for human consumption and must only be utilised by qualified researchers in appropriate laboratory environments following institutional research protocols and safety guidelines.
